473 related articles for article (PubMed ID: 16033898)
1. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.
Puzzo D; Vitolo O; Trinchese F; Jacob JP; Palmeri A; Arancio O
J Neurosci; 2005 Jul; 25(29):6887-97. PubMed ID: 16033898
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease.
Puzzo D; Palmeri A; Arancio O
Rev Neurosci; 2006; 17(5):497-523. PubMed ID: 17180876
[TBL] [Abstract][Full Text] [Related]
3. Exogenous nitric oxide causes potentiation of hippocampal synaptic transmission during low-frequency stimulation via the endogenous nitric oxide-cGMP pathway.
Bon CL; Garthwaite J
Eur J Neurosci; 2001 Aug; 14(4):585-94. PubMed ID: 11556884
[TBL] [Abstract][Full Text] [Related]
4. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β impairs, and ibuprofen restores, the cGMP pathway, synaptic expression of AMPA receptors and long-term potentiation in the hippocampus.
Monfort P; Felipo V
J Alzheimers Dis; 2010; 22(3):795-809. PubMed ID: 20858955
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
[TBL] [Abstract][Full Text] [Related]
7. Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.
Acquarone E; Argyrousi EK; van den Berg M; Gulisano W; Fà M; Staniszewski A; Calcagno E; Zuccarello E; D'Adamio L; Deng SX; Puzzo D; Arancio O; Fiorito J
Mol Neurodegener; 2019 Jun; 14(1):26. PubMed ID: 31248451
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.
Palmeri A; Ricciarelli R; Gulisano W; Rivera D; Rebosio C; Calcagno E; Tropea MR; Conti S; Das U; Roy S; Pronzato MA; Arancio O; Fedele E; Puzzo D
J Neurosci; 2017 Jul; 37(29):6926-6937. PubMed ID: 28626017
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus.
Lu YF; Kandel ER; Hawkins RD
J Neurosci; 1999 Dec; 19(23):10250-61. PubMed ID: 10575022
[TBL] [Abstract][Full Text] [Related]
10. Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus.
Lu YF; Hawkins RD
J Neurophysiol; 2002 Sep; 88(3):1270-8. PubMed ID: 12205148
[TBL] [Abstract][Full Text] [Related]
11. A novel role for cyclic guanosine 3',5'monophosphate signaling in synaptic plasticity: a selective suppressor of protein kinase A-dependent forms of long-term potentiation.
Makhinson M; Opazo P; Carlisle HJ; Godsil B; Grant SG; O'Dell TJ
Neuroscience; 2006 Jun; 140(2):415-31. PubMed ID: 16549271
[TBL] [Abstract][Full Text] [Related]
12. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
13. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide.
Chalimoniuk M; Strosznajder JB
Mol Chem Neuropathol; 1998; 35(1-3):77-95. PubMed ID: 10343972
[TBL] [Abstract][Full Text] [Related]
14. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
Wu MN; He YX; Guo F; Qi JS
Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
[TBL] [Abstract][Full Text] [Related]
15. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.
Monfort P; Muñoz MD; Felipo V
Neurobiol Dis; 2004 Feb; 15(1):1-10. PubMed ID: 14751765
[TBL] [Abstract][Full Text] [Related]
16. On the role of nitric oxide in hippocampal long-term potentiation.
Bon CL; Garthwaite J
J Neurosci; 2003 Mar; 23(5):1941-8. PubMed ID: 12629199
[TBL] [Abstract][Full Text] [Related]
17. Nitric-oxide-guanylyl-cyclase-dependent and -independent components of multiple forms of long-term synaptic depression.
Gage AT; Reyes M; Stanton PK
Hippocampus; 1997; 7(3):286-95. PubMed ID: 9228526
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism.
Paris D; Town T; Parker TA; Tan J; Humphrey J; Crawford F; Mullan M
Exp Neurol; 1999 May; 157(1):211-21. PubMed ID: 10222124
[TBL] [Abstract][Full Text] [Related]
19. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.
Zhuo M; Hu Y; Schultz C; Kandel ER; Hawkins RD
Nature; 1994 Apr; 368(6472):635-9. PubMed ID: 7908417
[TBL] [Abstract][Full Text] [Related]
20. Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase.
Gallo EF; Iadecola C
J Neurosci; 2011 May; 31(19):6947-55. PubMed ID: 21562256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
